Atlas Trials

Adjustment of Chemotherapy Duration in Follicular Lymphoma According to Minimal Residual Disease Status

Clinical trial NCT04934930 · UNKNOWN

Trial details

NCT number
NCT04934930
Sponsor
Meir Medical Center
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Follicular Lymphoma
Start date
2020-01-29
Primary completion
2025-08-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.